Israeli AI Firm Evogene Teams Up with Google Cloud to Accelerate Drug and Ag Research
Israeli AI firm Evogene partners with Google Cloud to integrate advanced AI agents into its ChemPass platform, accelerating drug and agriculture research and.
Jerusalem, 10 February, 2026 (TPS-IL) — Israeli computational chemistry company Evogene Ltd. is expanding its collaboration with Google Cloud to integrate advanced AI agents into its ChemPass AI platform. Based in Rehovot, Evogene develops AI-driven small-molecule design for pharmaceuticals and Agriculture.
The new phase aims to automate complex discovery workflows, accelerate molecular optimization, and improve efficiency across multiple programs. Building on a 2024 partnership that created a generative AI foundation model, the initiative highlights Israel’s growing role in cutting-edge AI and biotech innovation. Google Cloud Israel’s Boaz Maoz called the project “a leap in autonomous discovery at global scale.”
























